Carregant...
Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting
BACKGROUND: We examined the efficacy of olanzapine for the prevention of nausea and vomiting in patients receiving highly emetogenic chemotherapy. METHODS: In a randomized, double-blind, phase 3 trial, we compared olanzapine with placebo, in combination with dexamethasone, aprepitant or fosaprepitan...
Guardat en:
| Publicat a: | N Engl J Med |
|---|---|
| Autors principals: | , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5344450/ https://ncbi.nlm.nih.gov/pubmed/27410922 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1515725 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|